Generic Name : Aflibercept Therapeutic Classification : Glycoprotein
Internaional- Eylea. Why it is prescribed (Indications) :
This medication is a dimeric glycoprotein, prescribed for neovascular (Wet) age-related macular degeneration (AMD). It decreases the growth of certain cells in the eye. When it is not to be taken (Contraindications):
Contraindicated in patients with ocular or periocular infections, intraocular inflammation, and hypersensitivity.
Dosage & When it is to be taken :
Intravitreal- The recommended dose is 2 mg (0.05 mL or 50 microliters) administered by injection every 4 weeks (monthly) for 3 months, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). How it should be taken :
It comes as a solution for injection, to be administered by a healthcare provider into the eye. Warnings and Precautions :
* Caution should be exercised in patients with history of increased eye pressure, during pregnancy and breastfeeding.
* Patient may develop with increased risk of endophthalmitis and retinal detachments, blood clot events; if it is so consult with your doctor. Side Effects :
Most Common - Conjunctival bleeding, eye pain, cataract, vitreous detachment, increased eye pressure, foreign body sensation, increased tears, blurred vision, eye swelling.
* Avoid excess dosage. Storage Conditions :
Store it in refrigerator (2°C to 8°C).
Comment & Contribute
Ask an Expert